Actively Recruiting
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Led by Stéphane Zuily · Updated on 2026-05-08
500
Participants Needed
1
Research Sites
547 weeks
Total Duration
On this page
Sponsors
S
Stéphane Zuily
Lead Sponsor
I
International Society on Thrombosis and Haemostasis
Collaborating Sponsor
AI-Summary
What this Trial Is About
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
CONDITIONS
Official Title
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient receiving comprehensive information about the study and not opposed to participate
- Age 18 years or older
- Diagnosis of definite Antiphospholipid Syndrome according to revised Sapporo-Sydney criteria
- Currently prescribed direct oral anticoagulant treatment for at least 6 months or able to be followed for at least 6 months
You will not qualify if you...
- Incomplete revised Sapporo-Sydney criteria
- No data on recurrent thrombosis
- Pregnant women
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stéphane Zuily
Nancy, France, 54500
Actively Recruiting
Research Team
V
Virginie Dufrost, MD, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here